ReviewBiomolecules2020

Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers.

Chiao-En Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.